CAS: 2937327-93-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Bi-2865 REF: 54-OR1023298CAS: 2937327-93-8 | 98% | 1,967.00 €~4,329.00 € | Mon 28 Apr 25 |
| BI-2865 REF: 54-BUP03846CAS: 2937327-93-8 | 99% | 1,326.00 €~2,380.00 € | Mon 28 Apr 25 |
 | BI-2865 REF: TM-T72062CAS: 2937327-93-8 | 99.19% - 99.39% | 216.00 €~1,758.00 € | Mon 28 Apr 25 |
Ref: 54-OR1023298
| 100mg | 1,967.00 € | ||
| 250mg | 4,329.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Ref: 54-BUP03846
| 25mg | 1,326.00 € | ||
| 50mg | 1,750.00 € | ||
| 100mg | 2,380.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
BI-2865
CAS:2937327-93-8
BI-2865 is a non-covalent pan-KRAS inhibitor.Cost-effective and quality-assured.
Formula:
C23H27N7O2S
Purity:
99.19% - 99.39%
Color and Shape:
Soild
Molecular weight:
465.57
Ref: TM-T72062
| 1mg | 216.00 € | ||
| 5mg | 547.00 € | ||
| 10mg | 660.00 € | ||
| 25mg | 979.00 € | ||
| 50mg | 1,293.00 € | ||
| 100mg | 1,758.00 € | ||
| 1mL*10mM (DMSO) | 550.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
